Time-resolved T₁ and T₂ contrast for enhanced accuracy in MRI tumor detection

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Medical Imaging

Background:

• Stimuli-responsive contrast agents (CAs) enhance MRI for tumor diagnosis.
• Current CAs lack specificity and are affected by endogenous MRI artifacts.
• Need for advanced contrast agents with improved accuracy and reduced interference.

Purpose of the Study:

• To develop an extremely small iron oxide nanoparticle (ESIONP)-based smart responsive MRI contrast agent (LESPH).
• To achieve sequential dual biochemical stimuli-initiated, time-resolved T1 and T2 contrast presentation.
• To ensure high tumor specificity and minimize interference from endogenous artifacts.

Main Methods:

• ESIONPs were assembled with poly(2-(hexamethyleneimino) ethyl methacrylate) conjugated with a disulfide bond-linked catechol group (DSPH).
• Lauryl betaine was used as a surfactant in emulsion solvent evaporation.
• LESPH was designed to respond sequentially to tumor microenvironment stimuli (acidity and glutathione).

Main Results:

• LESPH exhibited a rapid transition from sparse assemblies to dispersed ESIONPs, followed by aggregation.
• Sequential responses to tumor microenvironment stimuli resulted in time-resolved T1 (brightening) and T2 (darkening) contrast.
• Distinguishable contrast enhancements were observed at different time scales, enabling precise tumor visualization.

Conclusions:

• LESPH demonstrates sequential dual responsiveness for time-resolved contrast enhancement.
• This novel agent achieves extremely high accuracy in tumor detection.
• LESPH offers a new paradigm for precise cancer diagnosis using MRI.